OR WAIT null SECS
Worldwide Clinical Trials announced its strategic partnership with Invitae. The partnership gives Worldwide access to Invitae’s Explorer tool—part of its real-world data platform that enables access to aggregated genetic testing results.
Through this partnership, Worldwide has access to data insights based on prevalence, incidence, demographics, geography, and epidemiology for rare disease patients.
Read more about this partnership here.